New hiv injectable drugs

The long fight against HIV/AIDS may get a potent new weapon. A new drug, taken by injection twice a year, shows great promise in preventing new HIV infections and would ease the treatment process

HIV infections among people who inject drugs (PWID) In 2024, PWID accounted for 7% (2,300) of the 31,800 estimated new HIV infections. Men who inject drugs accounted for 4% (1,300) of estimated new HIV infections. Women who inject drugs accounted for 3% (1,000) of estimated new HIV infections.

HIV diagnoses among people who inject drugs (PWID) In 2024, PWID accounted for 7% (2,651) of the 37,981 new HIV diagnoses. Men who inject drugs accounted for 4% (1,490) of new HIV diagnoses. Women who inject drugs accounted for 3% (1,161) of new HIV diagnoses.

Injection Drug Use and HIV Risk. Sharing needles, syringes, or other drug injection equipment (for example, cookers) puts people at risk for getting or transmitting HIV and other infections. About 1 in 10 . new HIV diagnoses in the United States . are attributed to injection drug use or male-to-male sexual contact and injection drug use. Risk

The new drug England hopes will help it defeat HIV for good in less than a decade is the long-acting injectable form of established HIV drug

drugs both lead to more frequent injections. In Philadelphia, the proportion of new HIV diagnoses attributed to injection drug use increased

Injecting drug use is found in nearly every country. Typically, when heroin injection reaches a new community, there is an exponential increase in HIV

Long-acting injectable drug prevents HIV infections. New AIDS strategy acts drugs that cripple the virus. In the new study, this combo marketed as

Men who inject drugs accounted for 4% (1,300) of estimated new HIV infections, while women who inject drugs accounted for 3% (1,000) of estimated new HIV infections. Among people who inject drugs, no changes were detected in the estimated annual number of HIV infections in 2024, compared with 2024.